GGrantIndex
← Leaderboards

Ranjan Dutta

Cleveland Clinic Lerner Com-Cwru

$3,783,325
Attributed
$5,833,054
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY201625
$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$5,833,054 · 4

By mechanism

R01$5,390,304 · 3
R21$442,750 · 1

Top collaborators

Most similar at Cleveland Clinic Lerner Com-Cwru

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsGenesAffectOligodendrogliaMyelinMouse ModelSpecificityPreventBrainMultiple Sclerosis PatientMultiple SclerosisDemyelinationsFutureLesionOligodendrocyte ProgenitorMediatingMolecularPathologyMultiple Sclerosis TreatmentCuprizoneOverexpressionCombinatorialLeadMultiple Sclerosis Lesions

Grant awards (14)

Childhood-onset hypomyelinating leukodystrophy and the multi-tRNA synthetase complex$626,635
R01 · FY2025 · NS
Understanding role of circadian disruption in pathogenesis of MS$427,291
R01 · FY2025 · NS · contact PI
Childhood-onset hypomyelinating leukodystrophy and the multi-tRNA synthetase complex$607,836
R01 · FY2024 · NS
Understanding role of circadian disruption in pathogenesis of MS$456,659
R01 · FY2024 · NS · contact PI
Childhood-onset hypomyelinating leukodystrophy and the multi-tRNA synthetase complex$626,635
R01 · FY2023 · NS
Understanding role of circadian disruption in pathogenesis of MS$470,782
R01 · FY2023 · NS · contact PI
Molecular correlates of sub-regional thalamic degeneration in multiple sclerosis$201,250
R21 · FY2023 · NS · contact PI
Understanding role of circadian disruption in pathogenesis of MS$440,871
R01 · FY2022 · NS · contact PI
Molecular correlates of sub-regional thalamic degeneration in multiple sclerosis$241,500
R21 · FY2022 · NS · contact PI
MicroRNAs as critical regulators of remyelination in Multiple Sclerosis$346,719
R01 · FY2020 · NS · contact PI
MicroRNAs as critical regulators of remyelination in Multiple Sclerosis$346,719
R01 · FY2019 · NS · contact PI
MicroRNAs as critical regulators of remyelination in Multiple Sclerosis$346,719
R01 · FY2018 · NS · contact PI
MicroRNAs as critical regulators of remyelination in Multiple Sclerosis$346,719
R01 · FY2017 · NS · contact PI
MicroRNAs as critical regulators of remyelination in Multiple Sclerosis$346,719
R01 · FY2016 · NS · contact PI